146 related articles for article (PubMed ID: 28114358)
1. Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP).
Hube L; Dohrn MF; Karsai G; Hirshman S; Van Damme P; Schulz JB; Weis J; Hornemann T; Claeys KG
PLoS One; 2017; 12(1):e0170583. PubMed ID: 28114358
[TBL] [Abstract][Full Text] [Related]
2. Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy.
Teunissen LL; Notermans NC; Jansen GH; Banga JD; Veldman H; Wokke JH
Acta Neuropathol; 2000 Oct; 100(4):445-50. PubMed ID: 10985705
[TBL] [Abstract][Full Text] [Related]
3. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
[TBL] [Abstract][Full Text] [Related]
4. Study of Autophagy and Microangiopathy in Sural Nerves of Patients with Chronic Idiopathic Axonal Polyneuropathy.
Samuelsson K; Osman AA; Angeria M; Risling M; Mohseni S; Press R
PLoS One; 2016; 11(9):e0163427. PubMed ID: 27662650
[TBL] [Abstract][Full Text] [Related]
5. Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people.
Vrancken AF; Franssen H; Wokke JH; Teunissen LL; Notermans NC
Arch Neurol; 2002 Apr; 59(4):533-40. PubMed ID: 11939887
[TBL] [Abstract][Full Text] [Related]
6. Microangiopathy-A Potential Contributing Factor to Idiopathic Polyneuropathy: A Mini Review.
Samuelsson K; Press R
Front Neurol; 2018; 9():43. PubMed ID: 29483890
[TBL] [Abstract][Full Text] [Related]
7. Chronic idiopathic axonal polyneuropathy: a systematic review.
Zis P; Sarrigiannis PG; Rao DG; Hewamadduma C; Hadjivassiliou M
J Neurol; 2016 Oct; 263(10):1903-10. PubMed ID: 26961897
[TBL] [Abstract][Full Text] [Related]
8. Pain-related changes in cutaneous innervation of patients suffering from bortezomib-induced, diabetic or chronic idiopathic axonal polyneuropathy.
Bechakra M; Nieuwenhoff MD; Rosmalen JV; Groeneveld GJ; J P M Huygen F; Zeeuw CI; Doorn PAV; Jongen JLM
Brain Res; 2020 Mar; 1730():146621. PubMed ID: 31926911
[TBL] [Abstract][Full Text] [Related]
9. Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome.
Visser NA; Vrancken AF; van der Schouw YT; van den Berg LH; Notermans NC
Diabetes Care; 2013 Apr; 36(4):817-22. PubMed ID: 23204246
[TBL] [Abstract][Full Text] [Related]
10. Increased Oxidative Stress as a Risk Factor in Chronic Idiopathic Axonal Polyneuropathy.
Zis P; McHugh PC; Manca M; Sarrigiannis PG; Rao DG; Hadjivassiliou M
J Mol Neurosci; 2018 Dec; 66(4):547-551. PubMed ID: 30350254
[TBL] [Abstract][Full Text] [Related]
11. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy.
Hoffman-Snyder C; Smith BE; Ross MA; Hernandez J; Bosch EP
Arch Neurol; 2006 Aug; 63(8):1075-9. PubMed ID: 16769858
[TBL] [Abstract][Full Text] [Related]
12. Impaired glucose tolerance and metabolic syndrome in idiopathic polyneuropathy: the role of pain and depression.
Rezania K; Soliven B; Rezai KA; Roos RP
Med Hypotheses; 2011 Apr; 76(4):538-42. PubMed ID: 21255940
[TBL] [Abstract][Full Text] [Related]
13. Chronic idiopathic axonal polyneuropathy: Electrophysiological progression and human leukocyte antigen associations.
Zis P; Sarrigiannis PG; Artemiadis A; Skarlatou V; Hadjivassiliou M
Muscle Nerve; 2021 Apr; 63(4):567-571. PubMed ID: 33440030
[TBL] [Abstract][Full Text] [Related]
14. Chronic axonal idiopathic polyneuropathy: is it really benign.
Samuelsson K; Press R
Curr Opin Neurol; 2020 Oct; 33(5):562-567. PubMed ID: 32773448
[TBL] [Abstract][Full Text] [Related]
15. Chronic idiopathic axonal polyneuropathy revisited.
Rosenberg NR; Vermeulen M
J Neurol; 2004 Sep; 251(9):1128-32. PubMed ID: 15372258
[TBL] [Abstract][Full Text] [Related]
16. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity of mitochondrial disease and dementia in patients with idiopathic polyneuropathy.
Samuelsson K; Mariosa D; Fang F; Press R
Eur J Neurol; 2018 Jun; 25(6):882-887. PubMed ID: 29505703
[TBL] [Abstract][Full Text] [Related]
18. Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?
Teunissen LL; Franssen H; Wokke JH; van der Graaf Y; Linssen WH; Banga JD; Laman DM; Notermans NC
J Neurol Neurosurg Psychiatry; 2002 May; 72(5):590-5. PubMed ID: 11971043
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathway.
Alecu I; Othman A; Penno A; Saied EM; Arenz C; von Eckardstein A; Hornemann T
J Lipid Res; 2017 Jan; 58(1):60-71. PubMed ID: 27872144
[TBL] [Abstract][Full Text] [Related]
20. Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy.
Notermans NC; Wokke JH; van den Berg LH; van der Graaf Y; Franssen H; Teunissen LL; Lokhorst HM
Brain; 1996 Apr; 119 ( Pt 2)():421-7. PubMed ID: 8800937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
